Goldman resumed coverage of Plains GP with a rating of Sell and set a new price target of $13.50
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/10/2025 | $22.00 | Peer Perform → Outperform | Wolfe Research |
| 12/18/2024 | $22.00 → $20.00 | Overweight → Equal Weight | Wells Fargo |
| 10/25/2024 | $22.00 → $19.00 | Overweight → Equal-Weight | Morgan Stanley |
| 4/8/2024 | $23.00 | Sector Outperform | Scotiabank |
| 10/6/2023 | $13.50 | Sell | Goldman |
| 9/25/2023 | $15.00 | Equal Weight → Underweight | Barclays |
| 9/6/2023 | $14.00 → $15.50 | Buy → Neutral | Citigroup |
| 4/21/2023 | $16.00 → $17.00 | Outperform → Strong Buy | Raymond James |
4 - PLAINS GP HOLDINGS LP (0001581990) (Issuer)
4 - PLAINS GP HOLDINGS LP (0001581990) (Issuer)
4 - PLAINS GP HOLDINGS LP (0001581990) (Reporting)
4 - PLAINS GP HOLDINGS LP (0001581990) (Issuer)